{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:21:57Z","timestamp":1791382917170,"version":"4.3.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"The study was supported by research grants from \u201cThe Brazilian National Council for Scientific and Technological Development (CNPq)","award":["#480292\/2009-4 and #309468\/2009-4"],"award-info":[{"award-number":["#480292\/2009-4 and #309468\/2009-4"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12882-017-0484-y","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T12:03:25Z","timestamp":1487160205000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Prevalence and risk factors for Human T-Lymphotropic Virus Type 1 (HTLV-1) among maintenance hemodialysis patients"],"prefix":"10.1186","volume":"18","author":[{"given":"Rilma F. S.","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gild\u00e1sio C.","family":"Concei\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcia S.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angiolina","family":"Kraychete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A. C.","family":"Penalva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar M.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Alberto","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Novis","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,15]]},"reference":[{"key":"484_CR1","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77:7415\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"484_CR2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","volume":"326","author":"A Gessain","year":"1985","unstructured":"Gessain A. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985;326:407\u201310.","journal-title":"Lancet"},{"key":"484_CR3","first-page":"1096","volume":"3","author":"JE Kaplan","year":"1990","unstructured":"Kaplan JE, Osame M, Kubota H, Igata A, Nishitani H, Maeda Y, Khabbaz RF, Janssen RS. The risk of development of HTLV-I-associated myelopathy\/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr. 1990;3:1096\u2013101.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"484_CR4","first-page":"423","volume":"15","author":"K Tajima","year":"1985","unstructured":"Tajima K, Kuroishi T. Estimation of rate of incidence of ATL among ATLV (HTLV-I) carriers in Kyushu, Japan. Jpn J Clin Oncol. 1985;15:423\u201330.","journal-title":"Jpn J Clin Oncol"},{"issue":"9 Suppl","key":"484_CR5","first-page":"4644s","volume":"45","author":"K Takatsuki","year":"1985","unstructured":"Takatsuki K, Yamaguchi K, Kawano F, Hattori T, Nishimura H, Tsuda H, Sanada I, Nakada K, Itai Y. Clinical diversity in adult T-cell leukemia-lymphoma. Cancer Res. 1985;45(9 Suppl):4644s\u20135.","journal-title":"Cancer Res"},{"key":"484_CR6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1590\/S0037-86822012000500002","volume":"45","author":"A Souza","year":"2012","unstructured":"Souza A, Tanajura D, Toledo-Cornell C, Santos S, de Carvalho EM. Immunopathogenesis and neurological manifestations associated to HTLV-1 infection. Rev Soc Bras Med Trop. 2012;45:545\u201352.","journal-title":"Rev Soc Bras Med Trop"},{"key":"484_CR7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/cid\/civ229","volume":"61","author":"D Tanajura","year":"2015","unstructured":"Tanajura D, Castro N, Oliveira P, Neto A, Muniz A, Carvalho NB, Orge G, Santos S, Glesby MJ, Carvalho EM. Neurological manifestations in Human T-cell Lymphotropic Virus Type 1 (HTLV-1)-infected individuals without HTLV-1-associated myelopathy\/tropical spastic paraparesis: a longitudinal cohort study. Clin Infect Dis. 2015;61:49\u201356.","journal-title":"Clin Infect Dis"},{"key":"484_CR8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2334-7-15","volume":"7","author":"PN Rocha","year":"2007","unstructured":"Rocha PN, Rehem AP, Santana JF, Castro N, Muniz AL, Salgado K, Rocha H, Carvalho EM. The cause of urinary symptoms among Human T Lymphotropic Virus Type I (HLTV-I) infected patients: a cross sectional study. BMC Infect Dis. 2007;7:15.","journal-title":"BMC Infect Dis"},{"key":"484_CR9","first-page":"459","volume":"17","author":"AQ-C Araujo","year":"2015","unstructured":"Araujo AQ-C. Update on neurological manifestations of HTLV-1 infection. Curr Infect Dis Rep. 2015;17:459.","journal-title":"Curr Infect Dis Rep"},{"key":"484_CR10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00296-009-1066-5","volume":"30","author":"AK Ferraz-Chaoui","year":"2010","unstructured":"Ferraz-Chaoui AK, Atta AM, Atta MLS, Galv\u00e3o-Castro B, Santiago MB. Study of autoantibodies in patients with keratoconjunctivitis sicca infected by the human T cell lymphotropic virus type 1. Rheumatol Int. 2010;30:775\u20138.","journal-title":"Rheumatol Int"},{"key":"484_CR11","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1086\/649871","volume":"50","author":"GP Garlet","year":"2010","unstructured":"Garlet GP, Giozza SP, Silveira EM, Claudino M, Santos SB, Avila-Campos MJ, Martins W, Cardoso CR, Trombone APF, Campanelli AP, Carvalho EM, Silva JS. Association of human T lymphotropic virus 1 amplification of periodontitis severity with altered cytokine expression in response to a standard periodontopathogen infection. Clin Infect Dis. 2010;50:e11\u20138.","journal-title":"Clin Infect Dis"},{"key":"484_CR12","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199304223281608","volume":"328","author":"P H\u00f6llsberg","year":"1993","unstructured":"H\u00f6llsberg P, Hafler DA. Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N Engl J Med. 1993;328:1173\u201382.","journal-title":"N Engl J Med"},{"key":"484_CR13","first-page":"205","volume":"11","author":"C Hlela","year":"2009","unstructured":"Hlela C, Shepperd S, Khumalo NP, Taylor GP. The prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown. AIDS Rev. 2009;11:205\u201314.","journal-title":"AIDS Rev"},{"key":"484_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2012.00388","volume":"3","author":"A Gessain","year":"2012","unstructured":"Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:1\u201323.","journal-title":"Front Microbiol"},{"key":"484_CR15","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","volume":"24","author":"FA Proietti","year":"2005","unstructured":"Proietti FA, Carneiro-Proietti ABF, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24:6058\u201368.","journal-title":"Oncogene"},{"key":"484_CR16","first-page":"424","volume":"13","author":"MR Hedayati-Moghaddam","year":"2011","unstructured":"Hedayati-Moghaddam MR, Fathimoghadam F, Eftekharzadeh Mashhadi I, Soghandi L, Bidkhori HR. Epidemiology of HTLV-1 in Neyshabour, Northeast of Iran. Iran Red Crescent Med J. 2011;13:424\u20137.","journal-title":"Iran Red Crescent Med J"},{"key":"484_CR17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM198807283190411","volume":"319","author":"GY Minamoto","year":"1988","unstructured":"Minamoto GY, Gold JWM, Scheinberg DA, Hardy WD, Chein N, Zuckerman E, Reich L, Dietz K, Gee T, Hoffer J, Mayer K, Gabrilove J, Clarkson B, Armstrong D. Infection with human T-cell leukemia virus type I in patients with leukemia. N Engl J Med. 1988;319:243\u20134.","journal-title":"N Engl J Med"},{"key":"484_CR18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00052359","volume":"2","author":"N Mueller","year":"1991","unstructured":"Mueller N. The epidemiology of HTLV-I infection. Cancer Causes Control. 1991;2:37\u201352.","journal-title":"Cancer Causes Control"},{"key":"484_CR19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","volume":"7","author":"K Verdonck","year":"2007","unstructured":"Verdonck K, Gonz\u00e1lez E, Van Dooren S, Vandamme A-M, Vanham G, Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis. 2007;7:266\u201381.","journal-title":"Lancet Infect Dis"},{"key":"484_CR20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1590\/S0037-86822002000500013","volume":"35","author":"ABF Carneiro-Proietti","year":"2002","unstructured":"Carneiro-Proietti ABF, Ribas JGR, Catalan-Soares BC, Martins ML, Brito-Melo GEA, Martins-Filho OA, Pinheiro SR, de Ara\u00fajo A Q-C, Galv\u00e3o-Castro B, de Oliveira MSP, Guedes AC, Proietti FA. Infection and disease caused by the human T cell lymphotropic viruses type I and II in Brazil. Rev Soc Bras Med Trop. 2002;35:499\u2013508.","journal-title":"Rev Soc Bras Med Trop"},{"key":"484_CR21","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1590\/S0102-311X2005000300027","volume":"21","author":"B Catalan-Soares","year":"2005","unstructured":"Catalan-Soares B, Carneiro-Proietti ABF, Proietti FA. Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I \/ II): serological screening prevalence rates in blood donors from large urban areas in Brazil. Cad Saude Publica. 2005;21:926\u201331.","journal-title":"Cad Saude Publica"},{"key":"484_CR22","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1537-2995.1995.35395184284.x","volume":"35","author":"OC Ferreira J\u00fanior","year":"1995","unstructured":"Ferreira J\u00fanior OC, Vaz RS, Carvalho MB, Guerra C, Fabron AL, Rosemblit J, Hamerschlak N. Human T-lymphotropic virus type I and type II infections and correlation with risk factors in blood donors from S\u00e3o Paulo, Brazil. Transfusion. 1995;35:258\u201363.","journal-title":"Transfusion"},{"key":"484_CR23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1537-2995.1997.37297203532.x","volume":"37","author":"B Galv\u00e3o-Castro","year":"1997","unstructured":"Galv\u00e3o-Castro B, Loures L, Rodriques LG, Sereno A, Ferreira J\u00fanior OC, Franco LG, Muller M, Sampaio DA, Santana A, Passos LM, Proietti F. Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study. Transfusion. 1997;37:242\u20133.","journal-title":"Transfusion"},{"key":"484_CR24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00126334-200312150-00013","volume":"34","author":"I Dourado","year":"2003","unstructured":"Dourado I, Alcantara LCJ, Barreto ML, da Gloria TM, Galv\u00e3o-Castro B. HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics. J Acquir Immune Defic Syndr. 2003;34:527\u201331.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"484_CR25","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/1097-0142(19871001)60:7<1474::AID-CNCR2820600712>3.0.CO;2-Y","volume":"60","author":"SY Lee","year":"1987","unstructured":"Lee SY, Mastushita K, Machida J, Tajiri M, Yamaguchi K, Takatsuki K. Human T-cell leukemia virus type I infection in hemodialysis patients. Cancer. 1987;60:1474\u20138.","journal-title":"Cancer"},{"key":"484_CR26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0272-6386(88)80120-3","volume":"12","author":"K Morikawa","year":"1988","unstructured":"Morikawa K, Kuroda M, Tofuku Y, Uehara H, Akizawa T, Kitaoka T, Koshikawa S, Sugimoto H, Hashimoto K. Prevalence of HTLV-1 antibodies in hemodialysis patients in Japan. Am J Kidney Dis. 1988;12:185\u201393.","journal-title":"Am J Kidney Dis"},{"key":"484_CR27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000184025","volume":"44","author":"A Rossi De","year":"1986","unstructured":"De Rossi A, Vertolli U, Romagnoli G, Bertoli M, Dalla Gassa O, Chieco-Bianchi L. LAV\/HTLV-III and HTLV-I antibodies in hemodialysis patients. Nephron. 1986;44:377\u20138.","journal-title":"Nephron"},{"key":"484_CR28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000186856","volume":"61","author":"JP M\u00e9ry","year":"1992","unstructured":"M\u00e9ry JP, Fessi H, Dosquet P, Dazza MC, Simon F, Elias A. HTLV-1 antibodies in hemodialysis patients. Nephron. 1992;61:124.","journal-title":"Nephron"},{"key":"484_CR29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00042560-199608150-00015","volume":"12","author":"C Devito","year":"1996","unstructured":"Devito C, Pampuro S, Del Pino N, Martinez Peralta L, Libonatti O. HTLV-I\/II survey on hemodialysis patients in Buenos Aires. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:525\u20136.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"484_CR30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1440-1797.2012.01603.x","volume":"17","author":"J Davies","year":"2012","unstructured":"Davies J, Jabbar Z, Gagan F, Baird RW. Blood-borne viruses in the haemodialysis-dependent population attending Top End Northern Territory facilities 2000\u20132009. Nephrology (Carlton). 2012;17:501\u20137.","journal-title":"Nephrology (Carlton)"},{"key":"484_CR31","first-page":"187","volume":"7","author":"J Ghaffari","year":"2013","unstructured":"Ghaffari J, Ebrahimi M, Makhlough A, Mohammadjafari H, Nazari Z. Seroepidemiology of human T-cell lymphotropic virus 1 infection in hemodialysis patients: should we be concerned about it? Iran J Kidney Dis. 2013;7:187\u201390.","journal-title":"Iran J Kidney Dis"},{"key":"484_CR32","doi-asserted-by":"crossref","first-page":"c35","DOI":"10.1159\/000286348","volume":"115","author":"GB Lopes","year":"2010","unstructured":"Lopes GB, Matos CM, Leite EB, Martins MTS, Martins MS, Silva LF, Robinson BM, Port FK, James SA, Lopes AA. Depression as a potential explanation for gender differences in health-related quality of life among patients on maintenance hemodialysis. Nephron Clin Pract. 2010;115:c35\u201340.","journal-title":"Nephron Clin Pract"},{"key":"484_CR33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11136-011-9964-x","volume":"21","author":"GB Lopes","year":"2012","unstructured":"Lopes GB, Nogueira FCP, de Souza MR, Penalva MA, de Amorim JL, Pisoni RL, Robinson BM, Lopes AA. Assessment of the psychological burden associated with pruritus in hemodialysis patients using the kidney disease quality of life short form. Qual Life Res. 2012;21:603\u201312.","journal-title":"Qual Life Res"},{"key":"484_CR34","unstructured":"Crit\u00e9rio ABIPEME. ftp:\/\/ftp.est.ufmg.br\/pub\/lupercio\/ABIPEME.doc ."},{"key":"484_CR35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0272-6386(89)80091-5","volume":"14","author":"G Perez","year":"1989","unstructured":"Perez G, Ortiz-Interian C, Lee H, de Medina M, Cerney M, Allain JP, Schiff E, Parks E, Parks W, Bourgoignie JJ. Human immunodeficiency virus and human T-cell leukemia virus type I in patients undergoing maintenance hemodialysis in Miami. Am J Kidney Dis. 1989;14:39\u201343.","journal-title":"Am J Kidney Dis"},{"key":"484_CR36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5301\/ijao.5000437","volume":"38","author":"F Fabrizi","year":"2015","unstructured":"Fabrizi F, Messa P. Transmission of hepatitis C virus in dialysis units: a systematic review of reports on outbreaks. Int J Artif Organs. 2015;38:471\u201380.","journal-title":"Int J Artif Organs"},{"key":"484_CR37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12882-015-0010-z","volume":"16","author":"L Sowole","year":"2015","unstructured":"Sowole L, Labbett W, Patel M, O\u2019Riordan A, Cross J, Davenport A, Haque T. The prevalence of occult hepatitis B virus (HBV) infection in a large multi-ethnic haemodialysis cohort. BMC Nephrol. 2015;16:12.","journal-title":"BMC Nephrol"},{"key":"484_CR38","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1590\/S0034-89102003000400012","volume":"37","author":"BC Soares","year":"2003","unstructured":"Soares BC, de Proietti Ab FC, Proietti FA. HTLV-I\/II and blood donors: determinants associated with seropositivity in a low risk population. Rev Saude Publica. 2003;37:470\u20136.","journal-title":"Rev Saude Publica"},{"key":"484_CR39","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.3390\/v7112904","volume":"7","author":"MR Hedayati-Moghaddam","year":"2015","unstructured":"Hedayati-Moghaddam MR, Tehranian F, Bayati M. Human T-Lymphotropic Virus Type I (HTLV-1) infection among Iranian blood donors: first case\u2013control study on the risk factors. Viruses. 2015;7:5736\u201345.","journal-title":"Viruses"},{"key":"484_CR40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00042560-199703010-00011","volume":"14","author":"GB Schreiber","year":"1997","unstructured":"Schreiber GB, Murphy EL, Horton JA, Wright DJ, Garfein R, Chien HC, Nass CC. Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: the Retrovirus Epidemiology Donor Study. NHLBI Retrovirus Epidemiology Donor Study. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:263\u201371.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"484_CR41","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/tme.12057","volume":"23","author":"SF O\u2019Brien","year":"2013","unstructured":"O\u2019Brien SF, Goldman M, Scalia V, Yi Q-L, Fan W, Xi G, Dines IR, Fearon MA. The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors. Transfus Med. 2013;23:358\u201366.","journal-title":"Transfus Med"},{"key":"484_CR42","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/archinte.1987.00370110053008","volume":"147","author":"JP Crowley","year":"1987","unstructured":"Crowley JP, Nealey TA, Metzger J, Pono L, Chazan JA. Transfusion and long-term hemodialysis. Arch Intern Med. 1987;147:1925\u20138.","journal-title":"Arch Intern Med"},{"key":"484_CR43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0268-960X(89)90010-6","volume":"3","author":"GJ Schiller","year":"1989","unstructured":"Schiller GJ, Berkman SA. Hematologic aspects of renal insufficiency. Blood Rev. 1989;3:141\u20136.","journal-title":"Blood Rev"},{"key":"484_CR44","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/ndt\/gfs575","volume":"28","author":"IC MacDougall","year":"2013","unstructured":"MacDougall IC, Obrador GT. How important is transfusion avoidance in 2013? Nephrol Dial Transplant. 2013;28:1092\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"484_CR45","first-page":"96","volume":"28","author":"TM Godinho","year":"2006","unstructured":"Godinho TM, Lyra TG, Braga PS, de Queiroz RA, Alves JA, Kraychete AC, Gusm\u00e3o ENA, Lopes AA, Rocha PN. Profile of patients initiating chronic hemodialysis at a public hospital in Brazil. J Bras Nefrol. 2006;28:96\u2013103.","journal-title":"J Bras Nefrol"},{"key":"484_CR46","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1080115","volume":"299","author":"T Igakura","year":"2003","unstructured":"Igakura T, Stinchcombe JC, Goon PKC, Taylor GP, Weber JN, Griffiths GM, Tanaka Y, Osame M, Bangham CRM. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science. 2003;299:1713\u20136.","journal-title":"Science"},{"issue":"Pt 12","key":"484_CR47","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1099\/vir.0.19334-0","volume":"84","author":"CRM Bangham","year":"2003","unstructured":"Bangham CRM. The immune control and cell-to-cell spread of human T-lymphotropic virus type 1. J Gen Virol. 2003;84(Pt 12):3177\u201389.","journal-title":"J Gen Virol"},{"key":"484_CR48","first-page":"476","volume":"36","author":"RC Sesso","year":"2014","unstructured":"Sesso RC, Lopes AA, Thom\u00e9 FS, Lugon JR, Dos Santos DR. Brazilian Chronic Dialysis Survey 2013 - trend analysis between 2011 and 2013. J Bras Nefrol. 2014;36:476\u201381.","journal-title":"J Bras Nefrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0484-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T13:50:50Z","timestamp":1719064250000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-017-0484-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,15]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["484"],"URL":"https:\/\/doi.org\/10.1186\/s12882-017-0484-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,15]]},"article-number":"64"}}